HOME | SITEMAP | CONTACT US









 
   
About the NCCR
Committee Members
Services & Guidelines
Approved Research
Clinical Investigators
Useful Links
NCCR Bulletin
MOH News
Contact Us







  Members of NCCR

The current composition of the NCCR was established to ensure that it becomes visionary and pro-active in driving the development of clinical research in the country.

The committee is made up of member representatives and experts from the Ministry of Health (MOH), various national Universities, the Malaysian Pharmaceutical Society (MPS), the Pharmaceutical Association of Malaysia (PhAMA), the Malaysian Organisation of Pharmaceutical Industries (MOPI), as well as other Non-Governmental Organisations. The composition of the member representatives reflects the on-going “smart-partnerships” amongst the various stake-holders with interests in quality clinical research in Malaysia.

The NCCR committee members for the 1 June 2016 – 31 May 2019 term are: 

Datuk Dr. Noor Hisham Bin Abdullah (Chairman)
Director General of Health Malaysia

Dr. Shahnaz Murad
Deputy Director General of Health Malaysia (Research and Technical Support)

Dato’ Dr Azman Hj Abu Bakar
Director of Medical Development Division, Ministry of Health Malaysia

Profesor Dato’ Paduka Dr. Khalid Hj. Yusoff
Vice Chancellor and President of UCSI University

Dato’ Dr. Chang Kian Meng
Chairman of the Medical Research and Ethics Committee, Ministry of Health Malaysia

Dr. Goh Pik Pin
Director of Clinical Research Centre Malaysia

Profesor Datin Dr. Zahurin Mohamed
Head of Pharmacology Department, University Malaya Medical Centre

Prof. Datuk Looi Lai Meng
Head of Pathology Department, University Malaya Medical Faculty

Dr. Salmah Bahri
Director of the National Pharmaceutical Regulatory Agency

Dr. Goh Cheng Soon
Director of the Traditional and Complimentary Medicines Division

Dr. Jasbir Singh Dhaliwal
Director of the Institute for Medical Research, Ministry of Health Malaysia

Dr. S. Asmaliza Ismail
Director of National Institute of Health Secretariat, Ministry of Health Malaysia

Profesor Dr. Yeoh Peng Nam
Representative form the Malaysia Pharmaceutical Society (MPS)

Dr. Akhmal Yusoff
CEO Clinical Research Malaysia

En. Zamane Abdul Rahman
Director of the Medical Device Bureau, Ministry of Health Malaysia

Dr. Kamaruzaman Saleh (Secretary)
Deputy Director National Pharmaceutical Regulatory Agency

Professor Datuk A. Rahman A. Jamal
Director of the UKM Medical Molecular Biology Institute

Dr. Sarojini Sivanandam
Representative from local Contract Research Organization (CRO)

Dr. Soraya Dato’ Seri Azmi
Alt. Representative from local Contract Research Organization (CRO)

En. Goh Tse Seng
Representative from International Contract Research Organization (CRO)

Puan Christine Siew Pui Yee,
Alt. Representative from International Contract Research Organization (CRO)

Pn Sabrina Haron
Representative from the Malaysian Organisation of Pharmaceutical Industries (MOPI)

Pn Vanessa Daniel
Alt. Representative from the Malaysian Organisation of Pharmaceutical Industries (MOPI)

Dr Ashwaria Gupta
Representative from Pharmaceutical Company

Dr Rubentiran Ramar
Alt. Representative from Pharmaceutical Company

 

Various Sub-committees are formed to facilitate the work and operations of the NCCR. These include:

•  Sub-committee on “Site Visit” for Clinical Research Infrastructure
This committee was established to identify the strengths and weaknesses of the present research centres infrastructure, and to take necessary actions in improving them so that clinical research can be carried out in Malaysia
•  Sub-committee for “Guidelines for Application to Conduct Drug-Related Clinical Trials in Malaysia”
Guidance for researchers and the pharmaceutical industries who are interested in conducting clinical research in Malaysia
•  Sub-committee for “Good Laboratory Practice” (GLP)
This committee was established to develop the Good Laboratory Practice (GLP) Guidelines and organise courses related to it
•  Sub-committee for Bio-Equivalence Studies (BE)
The “ASEAN Guidelines for the Conduct of Bioavailability and Bioequivalence Studies” which was prepared by Malaysia based on the "Malaysian Guidelines for the Conduct of Bioavailability and Bioequivalence Studies" was adopted by ASEAN with minor changes during the 8th ACCSQ PPWG Meeting in Bangkok, July 2004
•  Sub-Committee for Clinical Trial Import Licence
Guidance for researchers and the pharmaceutical industries who wish to import investigational products which are not registered in Malaysia for clinical research.

 

 



 Print Friendly [ Total Hits: 398512 | Page Hits: 28104 ]

 
 

This website is managed and sponsored by the Clinical Research Centre, Ministry of Health Malaysia
Copyright © 2005 - 2017 National Committee for Clinical Research (NCCR). All Rights Reserved.  
Powered by Cornerstone Content Management System